How We Can Personalize the Infliximab Use in Ulcerative Patients

How We Can Personalize the Infliximab Use in Ulcerative Patients

Saved in:

Bibliographic Details
Main Authors:	Mohammed Hussien Ahmed, Eslam Mohamed El Shennawy, Aya Mohammed Mahros
Format:	Article
Language:	English
Published:	Thieme Revinter Publicações Ltda. 2025-06-01
Series:	Journal of Coloproctology
Subjects:	infliximab response ulcerative colitis Egypt
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0045-1809670
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Predictors of infliximab efficacy in patients with severe attack of ulcerative colitis
by: A. O. Golovenko, et al.
Published: (2013-10-01)

Results of non-medical switching from original infliximab to its Russian biosimilar in patients with ulcerative colitis
by: Maria I. Timanovskaia, et al.
Published: (2025-01-01)

Case Report: Hemolytic anemia secondary to infliximab treatment in a patient with ulcerative colitis
by: Gerolamo Bevivino, et al.
Published: (2025-03-01)

Infliximab for patients with moderate to severely active ulcerative colitis: an updated meta-analysis of randomized controlled trials
by: Min Zhang, et al.
Published: (2025-07-01)

Case Presentation: a Facial Ulceration in a Patient with Ulcerative Colitis
by: Andreea GHIDERSA, et al.
Published: (2020-09-01)

Efficacy and Safety of Vedolizumab with Glucocorticoids vs Infliximabin Severe Ulcerative Colitis: A Retrospective Study
by: Zhang C, et al.
Published: (2025-06-01)

Hemorrhagic gastric ulcer in a patient with Behcet's disease successfully treated with infliximab
by: Shun Fujiwara, et al.
Published: (2023-04-01)

Cutaneous Kaposi’s Sarcoma Following Long-Term Infliximab Treatment in a Patient with HIV-Negative Antibiotic-Dependent Chronic Pouchitis: Considerations on an Exceptional Finding
by: Raffaele Pellegrino, et al.
Published: (2024-12-01)

TNF-α Inhibitor-Induced Psoriasis and Psoriatic Alopecia in Adolescent with Ulcerative Colitis: Clinical Case
by: Eduard T. Ambarchyan, et al.
Published: (2023-11-01)

Clear Cell Renal Carcinoma in an Ulcerative Colitis Patient Under Short-Term Immunosuppressive Therapy: A Case Report
by: Raffaele Pellegrino, et al.
Published: (2025-04-01)

Switching from intravenous to subcutaneous infliximab in patients with immune mediated diseases in clinical remission
by: Nikos Viazis, et al.
Published: (2025-05-01)

BIOLOGICAL THERAPY IN ADULT PATIENTS WITH ULCERATIVE COLITIS AND CROHN’S DISEASE: BUDGET IMPACT ANALYSIS
by: E. A. Pyadushkina
Published: (2017-05-01)

Acute severe ulcerative colitis: using JAK-STAT inhibitors for improved clinical outcomes
by: Shruthi Karthikeyan, et al.
Published: (2024-11-01)

Russian registry of Infliximab.Impact of therapy on the functional status of patients with rheumatoid arthritis
by: V N Amirdzhanova, et al.
Published: (2010-12-01)

Genetic Polymorphisms on TNFA, TNFRSF1A, and TNFRSF1B Genes Predict the Effectiveness of Anti-TNF-α Treatment in Inflammatory Bowel Disease Patients
by: Michelangelo Rottura, et al.
Published: (2025-03-01)

INFLIXIMAB: HAVE ALL QUESTIONS BEEN ANSWERED FOR 10 YEARS?
by: R M Balabanova, et al.
Published: (2010-03-01)

Infliximab in the therapy of rheumatoid arthritis
by: G. V. Lukina, et al.
Published: (2016-05-01)

INFLIXIMAB (REMICADE): POSSIBILITIES IN THE TREATMENT OF RHEUMATOID ARTHRITIS
by: Nataliya Vladimirovna Chichasova, et al.
Published: (2011-03-01)

Early versus late initiation of infliximab for refractory uveitis in a cohort of Egyptian BD patients
by: Mariam R Fadel, et al.
Published: (2024-08-01)

QUANTITATIVE APPROACH TO ASSESSMENT OF THERAPEUTIC RESPONSE ON EARLY STAGES OF ULCERATIVE COLITIS TREATMENT
by: M. A. Fedosova, et al.
Published: (2016-12-01)

THE EXPERIENCE OF INFLIXIMAB USAGE IN JUVENILE ARTHRITIS IN THE REPUBLIC OF BASHKORTOSTAN
by: V. A. Malievskii, et al.
Published: (2012-11-01)

Comparative efficacy of infliximab and adalimumab in patients with ankylosing spondylitis
by: Tatyana Valentinovna Mezenova, et al.
Published: (2012-04-01)

Advances in surgical treatment of ulcerative colitis associated colorectal cancer
by: He-Yuan NIU, et al.
Published: (2023-12-01)

Experience with long-term infliximab therapy in patients with ankylosing spondylitis
by: Oksana Alekseevna Rumyantseva, et al.
Published: (2010-12-01)

ATTEMPT OF OVERCOMING SECONDARY INEFFECTIVENESS OF INFLIXIMAB IN A PATIENT WITH ANKYLOSING SPONDYLITIS USING PLASMAPHERESIS (A CASE REPORT)
by: Oksana Alekseyevna Rumyantseva, et al.
Published: (2014-02-01)

Malignant perforation of sigmoid colon in long-standing ulcerative colitis
by: G K Adithya, et al.
Published: (2020-01-01)

Malignant perforation of sigmoid colon in long-standing ulcerative colitis
by: G K Adithya, et al.
Published: (2019-01-01)

Toll-like Receptor Gene Polymorphisms as Predictive Biomarkers for Response to Infliximab in Japanese Patients with Crohn’s Disease
by: Jingjing Wei, et al.
Published: (2025-04-01)

Comparison of endoscopic healing and durability between combination therapy with infliximab and azathioprine versus infliximab monotherapy in pediatric Crohn’s disease
by: Yoon Zi Kim, et al.
Published: (2025-07-01)

Revisión: Infliximab, desarrollo y aplicación terapéutica
by: Mildred Angelica Sauce Guevara, et al.
Published: (2025-06-01)

An adolescent case of extensive Behçet`s disease successfully treated with Infliximab
by: Emel Isıyel, et al.
Published: (2019-08-01)

Intestinal and extraintestinal manifestations of ulcerative colitis: correlation with Mayo scores
by: Mohamed Elegezy, et al.
Published: (2025-07-01)

Real-world assessment of effectiveness and safety of filgotinib in 286 patients with ulcerative colitis in 9 UK centres
by: David Young, et al.
Published: (2025-01-01)

The efficacy of infliximab combined with partial enteral nutrition in the treatment of Crohn’s disease: a cohort study
by: Chen Huang, et al.
Published: (2025-06-01)

Effect of HLA-B27 status and body mass index on the clinical response to infliximab in ankylosing spondylitis patients
by: Mohammed Hadi Al-Osami, et al.
Published: (2018-01-01)

EFFICACY OF INFLIXIMAB IN RHEUMATOID ARTHRITIS: A RELATIONSHIP TO THE TOTAL DOSE OF THE DRUG
by: E. S. Aronova, et al.
Published: (2015-10-01)

CLINICAL MANIFESTATION, DIAGNOSTICS AND TREATMENT OF ULCERATIVE COLITIS IN CHILDREN: RUSSIAN PEDIATRIC CONSENSUS
by: A. S. Potapov, et al.
Published: (2013-05-01)

THE MODERN VIEW OF THE PATHOGENESIS AND LABORATORY DIAGNOSTICS OF ULCERATIVE COLITIS (LITERATURE REVIEW)
by: V. I. Sovalkin, et al.
Published: (2017-08-01)

A Comparison of Intravenous Infliximab Versus Subcutaneous Infliximab on Remission Rates, Safety, Costs, Patient Preferences in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
by: Alejandro Nieto Dominguez, et al.
Published: (2025-01-01)

Is Infection Associated With Ulcerative Colitis Activity?
by: Ayoung Lee, et al.
Published: (2024-03-01)